LANZA, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 14.978
AS - Asia 9.939
EU - Europa 5.006
SA - Sud America 2.128
AF - Africa 254
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 10
Totale 32.346
Nazione #
US - Stati Uniti d'America 14.624
SG - Singapore 3.919
CN - Cina 1.981
BR - Brasile 1.694
VN - Vietnam 1.156
PL - Polonia 1.118
HK - Hong Kong 1.047
IT - Italia 917
UA - Ucraina 603
DE - Germania 588
FR - Francia 364
GB - Regno Unito 356
BD - Bangladesh 340
TR - Turchia 331
FI - Finlandia 324
RU - Federazione Russa 296
JP - Giappone 266
ID - Indonesia 258
IN - India 201
AR - Argentina 162
MX - Messico 153
SE - Svezia 139
CA - Canada 117
ZA - Sudafrica 105
IQ - Iraq 82
EC - Ecuador 81
CO - Colombia 57
NL - Olanda 57
ES - Italia 55
PK - Pakistan 47
AT - Austria 38
MY - Malesia 38
UZ - Uzbekistan 36
VE - Venezuela 34
PY - Paraguay 32
SA - Arabia Saudita 31
MA - Marocco 30
CL - Cile 28
AU - Australia 26
BE - Belgio 26
KE - Kenya 25
AE - Emirati Arabi Uniti 23
JM - Giamaica 21
CZ - Repubblica Ceca 20
TN - Tunisia 19
PH - Filippine 18
EG - Egitto 17
LT - Lituania 17
TW - Taiwan 17
IL - Israele 16
JO - Giordania 16
PE - Perù 16
DZ - Algeria 14
AZ - Azerbaigian 13
NP - Nepal 13
TH - Thailandia 13
BO - Bolivia 12
DO - Repubblica Dominicana 11
ET - Etiopia 11
IR - Iran 11
TT - Trinidad e Tobago 11
UY - Uruguay 11
BG - Bulgaria 10
CR - Costa Rica 9
LB - Libano 9
RO - Romania 9
IE - Irlanda 8
KR - Corea 8
OM - Oman 8
KG - Kirghizistan 7
MD - Moldavia 7
PA - Panama 7
PS - Palestinian Territory 7
RS - Serbia 7
AL - Albania 6
CH - Svizzera 6
KZ - Kazakistan 6
LV - Lettonia 6
SV - El Salvador 6
CI - Costa d'Avorio 5
NI - Nicaragua 5
NZ - Nuova Zelanda 5
SK - Slovacchia (Repubblica Slovacca) 5
AO - Angola 4
EU - Europa 4
GR - Grecia 4
HN - Honduras 4
PT - Portogallo 4
QA - Qatar 4
SI - Slovenia 4
BB - Barbados 3
BH - Bahrain 3
GE - Georgia 3
KH - Cambogia 3
MT - Malta 3
MU - Mauritius 3
PR - Porto Rico 3
SN - Senegal 3
XK - ???statistics.table.value.countryCode.XK??? 3
A2 - ???statistics.table.value.countryCode.A2??? 2
Totale 32.305
Città #
Singapore 2.241
Ashburn 1.772
Fairfield 1.508
Woodbridge 1.119
Warsaw 1.109
Hong Kong 1.037
Houston 946
San Jose 895
Santa Clara 696
Beijing 636
Wilmington 624
Jacksonville 623
Seattle 586
Chandler 538
Ann Arbor 517
Cambridge 487
Ho Chi Minh City 369
Princeton 312
Lauterbourg 253
Tokyo 247
Council Bluffs 236
Hanoi 215
Milan 208
New York 196
Izmir 187
Nanjing 186
Jakarta 184
Dallas 174
Helsinki 172
Los Angeles 164
San Diego 160
São Paulo 136
Dong Ket 115
Mexico City 100
Boardman 81
Shanghai 78
Moscow 73
Munich 73
London 62
Nanchang 61
Buffalo 59
Chicago 58
Rome 57
Shenyang 57
Falls Church 50
Da Nang 47
Orem 47
Rio de Janeiro 46
Redwood City 45
Bremen 44
Johannesburg 44
Belo Horizonte 42
Brasília 41
Chennai 40
Haiphong 40
Hebei 39
Tianjin 39
Ferrara 38
Changsha 37
Atlanta 35
Norwalk 35
Jiaxing 34
Montreal 33
Mountain View 33
Toronto 33
Curitiba 32
Tashkent 32
Guangzhou 31
Turku 31
Nuremberg 30
Denver 28
Hefei 27
Baghdad 26
Quito 26
Brooklyn 25
Frankfurt am Main 25
Stockholm 25
Biên Hòa 24
Campinas 24
Zhengzhou 24
Guayaquil 23
Brussels 22
Dearborn 22
Salvador 22
Bologna 21
Fortaleza 21
Kunming 20
Nairobi 20
Buenos Aires 19
Dhaka 19
Jinan 19
Kuala Lumpur 19
Boston 18
Amsterdam 17
Hải Dương 17
Lahore 17
Medellín 17
Naples 17
Istanbul 16
Mumbai 16
Totale 21.241
Nome #
Predictive value of hematological and phenotypical parameters on postchemotherapy leukocyte recovery 321
Aberrant expression of HLA-DR antigen by bone marrow-derived mesenchymal stromal cells from patients affected by acute lymphoproliferative disorders 295
CXCR4 pos circulating progenitor cells coexpressing monocytic and endothelial markers correlating with fibrotic clinical features are present in the peripheral blood of patients affected by systemic sclerosis 289
Individual quality assessment of autografting by probability estimation for clinical endpoints: a prospective validation study from the European group for blood and marrow transplantation 270
A decreased positivity for CD90 on human mesenchymal stromal cells (MSCs) is associated with a loss of immunosuppressive activity by MSCs 266
Preferential expression of the transcription coactivator HTIF1alpha gene in acute myeloid leukemia and MDS-related AML 260
A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells from different sources. Evidence of discordant reactivity for various immunological markers 254
A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells 250
Identification of Chlamydia trachomatis in a patient with ocular lymphoma 244
CD34+ cell subsets and long-term culture colony-forming cells evaluated on both autologous and normal bone marrow stroma predict long-term hematopoietic engraftment in patients undergoing autologous peripheral blood stem cell transplantation 238
Deficiency of polycystin-2 reduces Ca2+ channel activity and cell proliferation in ADPKD lymphoblastoid cells 236
Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes 224
RABBIT IgG ANTIBODIES AGAINST CORD RED BLOOD CELL MEMBRANES BIND TO COMPLEMENT RECEPTOR 1 (CD35) 224
FIBROBLASTS INCREASE ADHESION TO NEUTROPHILS AFTER STIMULATION WITH PHORBOL ESTER AND CYTOKINES 223
Angiogenesis in multiple myeloma: Correlation between in vitro endothelial colonies growth (CFU-En) and clinical-biological features 221
Evaluation of CR1 expression in neutrophils from chronic myeloid leukaemia: relationship between prognosis and cellular activity 213
Cotransplantation of mesenchymal cells and a higher relapse rate: a role for HLA-G molecules? 212
PCR con primer degenerati non evidenza sequenze virali di HHV8 nè di una sua variante in cellule stromali midollari di pazienti affetti da gammopatie monoclonali 206
Immunosuppressive properties of mesenchymal stromal cells 205
The Sorafenib plus Nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of the FLT3 and p53 status 203
Assessment of distribution of CD34 epitope classes in fresh and cryopreserved peripheral blood progenitor cells and acute myeloid leukemic blasts 194
Expression of the immunoglobulin superfamily cell membrane adhesion molecule Cd146 in acute leukemia 191
Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib 188
CXCR-4 Expression on bone marrow CD34+ cells prior to mobilization can predict mobilization adequacy in patients with hematologic malignancies 187
Multiparametric flow cytometric characterization of circulating stem cell subsets in patients with myocardial infarction: correlation with clinical and biological data 186
A comparative analysis of biosimilar vs. originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma: a propensity-score weighted multicenter approach 185
BCR-ABL rearrangement is not detectable in essential thrombocythemia 184
Citometria a flusso: applicazioni in ematologia 184
DEPRESSED NEUTROPHIL-MEDIATED TUMOR CELL CYTOTOXICITY IN SUBJECTS AFFECTED BY HEREDITARY MYELOPEROXIDASE DEFICIENCY AND SECONDARY NEOPLASIA 183
Soluble HLA-G molecules in follicular fluid: a tool for oocyte selection in IVF? 183
Differences among young adults, adults and elderly chronic myeloid leukemia patients 183
Isolation of stem cell populations with trophic and immunoregulatory functions from human intestinal tissues: potential for cell therapy in inflammatory bowel disease 181
Adverse haematological effects of ticlopidine. A report of four cases 177
GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia 177
Study of prognosis in acute myeloid leukemias (AML) by cluster analysis 176
Postremission Consolidation by Autologous Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia in First Complete Remission (CR) and Negative Implications for Subsequent Allogeneic HCT in Second CR: A Study by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT) 176
Comparison of single and dual platform methodologies for the estimation of CD34+ hematopoietic progenitor cells: correlation with colony assay 173
New monoclonal antibodies and tyrosine kinase inhibitors in B-cell acute lymphoblastic leukemia 173
Assessment of bone marrow-derived endothelial cells in non-Hodgkin's lymphoma patients undergoing peripheral blood stem cell transplantation 172
CD34 quantitative flow cytometry study of the blastic population in acute leukemias 171
Alloreactivity: the Janus-face of hematopoietic stem cell transplantation 170
p53 exon 5 mutation in two cases of leukemic mantle cell lymphoma 169
Thrombocytosis in systemic lupus erythematosus: a possible clue to autosplenectomy? 168
Flow cytometry measurement of GM-CSF receptors in acute leukemic blasts, and normal hemopoietic cells 166
Treatment of Adult Patients with Relapsed/Refractory B-Cell Philadelphia-Negative Acute Lymphoblastic Leukemia 166
Assessment of growth of endothelial cells and fibroblasts in long-term cultures of patients with haematological malignancies. 164
Administration of high-dose chemotherapy with stem cell support in patients 40 years of age or older with advanced germ cell tumours: A retrospective study from the European Society for Blood and Marrow Transplantation database 164
Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study 164
Trapianto autologo di cellule staminali in paziente affetta da sclerosi sistemica a varietà diffusa. 161
Absence of HTLV-1 in myelodysplastic syndromes in an area non endemic for HTLV-1 infection. 160
Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: Current practice in Europe, 2015 159
PCR with degenerate primers for highly conserved DNA polymerase gene of the herpesvirus family shows neither human herpesvirus 8 nor a related variant in bone marrow stromal cells from multiple myeloma patients 158
Thiotepa, busulfan and fludarabine compared to busulfan and cyclophosphamide as conditioning regimen for allogeneic stem cell transplant from matched siblings and unrelated donors for acute myeloid leukemia 158
Studio dei progenitori emopoietici circolanti in pazienti con infarto del miocardio 158
A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana Linfomi 156
IL-8 enhances antibody-dependent cellular cytotoxicity in human neutrophils 155
CD34+CD33+ blast cells: Correlation with FAB subtypes 155
Improved outcome of patients with relapsed/refractory Hodgkin lymphoma with a new fotemustine-based high-dose chemotherapy regimen 155
Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial 155
AIDS associated non Hodgkin’s lymphoma in Italy: intraveneous drug users versus homosexual men 150
Cellule staminali circolanti in pazienti con infarto miocardico. 148
Cellule staminali circolanti in pazienti con infarto miocardico 147
Loss of Thy-1 (CD90) antigen expression on mesenchymal stromal cells from hematologic malignancies is induced by in vitro angiogenic stimuli and is associated with peculiar functional and phenotypic characteristics 144
Isolamento e caratterizzazione immunofenotipica di cellule non-emopoietiche presenti in versamenti ascitici e pleurici di pazienti con malattie ematologiche 143
null 142
CD87 (urokinase-type plasminogen activator receptor), function and pathology in hematological disorders: a review 142
Polymorphonuclear neutrophils pulsed with synthetic peptides efficiently activate memory cytotoxic T lymphocytes 141
Post-thaw viability of cryopreserved peripheral blood stem cells: what are we actually looking at? 140
Chlamydia trachomatis and Ocular Lynphoma. a possible link? 139
Bone marrow stromal cells in acute promyelocytic leukaemia: comparison with other acute myelogenous leukaemia subtypes. 138
In vitro expansion and immunophenotypic characterization of circulating stem celle in patients affected by systemic scleoris (SSc): possible implications in fibrosis process 137
Adjuvant high-dose chemotherapy with autologous hematopoietic stem cell transplantation for high-risk breast cancer: results from the italian National Registry 137
Novel Applications for the Flow Cytometry 137
High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment in High-Risk Breast Cancer: Data from the European Group for Blood and Marrow Transplantation Registry 135
A simple method to identify bone marrow mesenchymal stromal cells with a high immunosuppressive potential 132
Presenza di molecole solubili HLA-G nel plasma da cordone ombelicale: un possibile marcatore di tolerogenicità? 131
Impact of drug development on the use of stem cell transplantation: A report by the European Society for Blood and Marrow Transplantation (EBMT) 131
Acute leukemia following a previous malignancy: do acute lymphoid leukemia and acute myeloid leukemia have a common risk factors ? 131
Cellule mesenchimali stromali: caratterizzazione immunofenotipica e funzionale 130
FLOW CYTOMETRY STUDY OF CR1, CR3 AND GRANULE CONSTITUENTS IN NEUTROPHILS OF MDS PATIENTS AND HEALTHY CONTROLS: RELATIONSHIP WITH FUNCTIONAL ACTIVITIES AND DISEASE STATES 130
Expression and functional role of urokinase-type plasminogen activator receptor in normal and acute leukaemic cells 130
An Overview of Current Position on Cell Therapy in Transfusion Science and Medicine: From Fictional Promises to Factual and Perspectives from Red Cell Substitution to Stem Cell Therapy 129
Secondary malignancies after high-dose chemotherapy in germ cell tumor patients: A 34-year retrospective study of the European Society for Blood and Marrow Transplantation (EBMT) 129
Autologous stem cell transplantation: is it still relevant in breast cancer? 127
Move on air: Webinar for education in stem cells mobilization Report I 125
Ibrutinib: from bench side to clinical implications 124
Studio immunofenotipico nelle leucemie acute mieloidi (LMA): significato biologico ed implicazioni prognostiche 124
Functional and immunophenotypic characteristics of isolated CD105+ and fibroblasts+ mesenchymal cells from acute myeloid leukaemia: implication for their plasticity along endothelial lineage 123
Predicting failure of hematopoietic stem cell mobilization before it starts: The predicted poor mobilizer (pPM) score 121
Abnormal epression of N-CAM (CD56) adhesion molecule on myeloid and progenitor cells from chronic myeloid leukaemia 121
Novel Insights in Anti-CD38 Therapy Based on CD38-Receptor Expression and Function: The Multiple Myeloma Model 121
NEUTROPHILS FROM PATIENTS WITH MYELODISPLASTIC SYNDROMES: RELATIONSHIP BETWEEN IMPAIRMENT OF GRANULAR CONTENTS, COMPLEMENT RECEPTORS, FUNCTIONAL ACTIVITIES AND DISEASE STATUS 120
Clinical applications of mesenchymal stromal cells in stem cell transplantation 120
CXCR4 circulating progenitor cells coexpressing monocytic and endothelial markers may be involved in the pathogenesis of fibrosis in systemic sclerosis 119
Alpha interferon in T helper phenotype chronic lymphocytic leukemia: a report of three cases 118
Trends and targets of various types of stem cell derived transfusable RBC substitution therapy: Obstacles that need to be converted to opportunity 117
Potential clinical application of rhGM-CSF in acute myeloid leukemia based on its biological activity and receptor interaction 117
"In vitro" evaluation of bone marrow angiogenesis in myelodysplastic syndromes: A morphological and functional approach 117
Factors affecting successful mobilization with plerixafor: An Italian prospective survey in 215 patients with multiple myeloma and lymphoma 117
Features, reason for testing, and changes with time of 583 paroxysmal nocturnal hemoglobinuria clones from 529 patients: a multicenter Italian study 117
Totale 16.880
Categoria #
all - tutte 181.697
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 6.675
Totale 188.372


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021195 0 0 0 0 0 0 0 0 0 0 0 195
2021/20222.419 198 348 74 131 75 80 123 169 110 284 151 676
2022/20231.650 306 54 71 265 216 207 55 144 177 21 84 50
2023/2024868 87 89 61 35 52 67 25 50 27 18 34 323
2024/20254.700 159 55 481 111 563 260 92 195 792 967 569 456
2025/202613.377 1.012 639 1.384 1.965 1.709 699 1.214 831 1.194 1.813 746 171
Totale 33.037